4basebio jobs and careers
Cambridge, United Kingdom
About 4basebio
4basebio is enabling next generation cell and gene therapies and vaccines with its technologies and solutions. We are able to design, manufacture and supply application-specific synthetic DNA or mRNA as well as targeted non-viral vectors for the delivery of nucleic acid payloads. Our novel synthetic DNA technology offers unique customisation potential, rapid turn-around times, and improved safety profiles, addressing the current limitations of plasmids and other DNA technologies. We currently offer four DNA construct types, each ideally suited for use in viral and non-viral vector applications, genome editing, vaccines and therapeutics, and DNA vaccine applications, respectively. Our proprietary non-viral delivery system, Hermes™, is a nanoparticle vector that can be customised to target cells or tissues of interest for a range of applications. This combines the safety and efficiency of lipid-based nanoparticles (LNPs) with the specificity of a targeting system, addressing the shortcoming associated with both viral vectors and non-targeted LNPs.
- Founded
- 1997
- Employees
- 11 to 50
- Total funding
- $299K
- Headquarters
- Cambridge
Leadership
The top of 4basebio's org chart, with how many people report into each leader.
Heikki Lanckriet
CEO/Chief Scientific Officer
59 reports
Amy Walker
Chief Executive Officer
20 reports
Zoe Whiffen
Senior Director - RUO Operations / MSAT
15 reports
Jennifer Hynes
VP of Quality
12 reports
Christine Wolosin
Chief Commercial Officer
6 reports
David Roth
CFO
1 report
Jobs at 4basebio
No open positions right now. Explore more companies on TheJobsMap.